Princess Ghida Talal Named Top Oncology Leader
OncoDaily ranked HRH Princess Ghida Talal among the world's 100 most influential women in oncology for 2026.
Updated on Nov. 3, 2026 in Cancer
OncoDaily named HRH Princess Ghida Talal among the world's 100 most influential women in oncology for 2026. The recognition reflects 25 years of her work advancing cancer care through the King Hussein Cancer Foundation and Center.
Why it matters
The ranking highlights leadership in cancer care across the Arab region, where access to comprehensive treatment and research support has been expanded through the King Hussein Cancer Center. It also draws attention to efforts to build regional research capacity.
The ranking is an annual OncoDaily listing of influential figures in oncology, and the King Hussein Cancer Center serves more than 85,000 patients. The selection criteria and the timeframe covered by the patient count are not detailed in the source.
The players
HRH Princess Ghida Talal
A member of the Jordanian royal family who chairs the King Hussein Cancer Foundation and Center and has led its cancer care and research initiatives.
OncoDaily
A global oncology platform that publishes an annual ranking of influential figures in the field.
King Hussein Cancer Foundation
The Jordan-based foundation that operates the King Hussein Cancer Center and supports cancer treatment and research in the region.
The details
Princess Ghida Talal chairs the King Hussein Cancer Foundation and Center, which has become an internationally accredited cancer treatment facility. The King Hussein Cancer Foundation issued a statement announcing the recognition on November 3, 2026.
Timeline
2020: Princess Ghida Talal established the King Hussein Cancer Research Award to support Arab researchers in cancer studies.
November 3, 2026: The King Hussein Cancer Foundation announced the OncoDaily recognition.
Health Landscape
The recognition extends the King Hussein Cancer Center's standing as an internationally accredited cancer facility, following its growth into a provider of comprehensive care for more than 85,000 patients. It places regional cancer leadership alongside the broader push to expand research capacity in the Arab region through the King Hussein Cancer Research Award.
Expanded access to comprehensive cancer treatment at accredited centers can shape the options available to patients seeking care in the region. The King Hussein Cancer Center's growth to serving more than 85,000 patients reflects the scale of care that is now available.
The takeaway
Recognition of leaders like Princess Ghida Talal highlights how sustained investment in cancer research and accredited treatment can expand care over decades. Readers interested in cancer care can track how regional research awards and treatment centers continue to grow.
Further reading
For more on the disease at the center of this recognition, explore our coverage of Cancer.
Source note: This article includes information reported by وكاله عمون الاخباريه.
